Human epidermal growth factor receptor 2 overexpression is associated with high-grade tumors in upper tract urothelial carcinoma

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 10

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Oct 24, 2025; 16(10): 110047
Published online Oct 24, 2025. doi: 10.5306/wjco.v16.i10.110047

Full Size Figure Download Figure

Figure 3 The representative immunohistochemical staining patterns of CK20 and CK5/6. A: CK20; B: CK5/6; Original magnification, × 200.

Citation: Huang L, He J. Human epidermal growth factor receptor 2 overexpression is associated with high-grade tumors in upper tract urothelial carcinoma. World J Clin Oncol 2025; 16(10): 110047
URL: https://www.wjgnet.com/2218-4333/full/v16/i10/110047.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i10.110047

Huang L, He J. Human epidermal growth factor receptor 2 overexpression is associated with high-grade tumors in upper tract urothelial carcinoma. World J Clin Oncol 2025; 16(10): 110047 [PMID: 41178915 DOI: 10.5306/wjco.v16.i10.110047]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.